Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 52, Issue 6
Volume 52, Issue 6
15 March 2011
ISSN 1058-4838
EISSN 1537-6591

Volume 52, Issue 6, 15 March 2011

15 March News

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages i–ii, https://doi.org/10.1093/cid/cir059

In the Literature

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages iii–iv, https://doi.org/10.1093/cid/ciq223

MAJOR ARTICLES AND COMMENTARIES

Jaime E. Hernandez and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 695–706, https://doi.org/10.1093/cid/cir001

Peramivir, an investigational intravenous neuraminidase inhibitor, was given to 31 hospitalized patients with severe viral pneumonia during the 2009 H1N1 influenza pandemic under the Emergency IND regulations. The drug was generally well tolerated and associated with recovery in most patientes.

Seema Jain and Alicia M. Fry
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 707–709, https://doi.org/10.1093/cid/cir010
Sophie Blumental and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 710–716, https://doi.org/10.1093/cid/ciq189

Case report of a trisomic infant with cardiac prosthetic device who presented three recurrences of culture negative endocarditis. Coxsackie virus was the only pathogen recovered from the endocardial tissue and its role as etiological agent of the infection is discussed.

Gavin C. K. W. Koh and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 717–725, https://doi.org/10.1093/cid/ciq192

Patients with diabetes have better survival from septic melioidosis than patients who without diabetes. This difference was seen only in patients taking glyburide prior to presentation and was associated with an anti-inflammatory effect of glyburide.

Jessica M. Valdez and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 726–735, https://doi.org/10.1093/cid/ciq245

Survival in aplastic anemia has markedly improved in recent decades. In multivariate analysis, the introduction of newer antifungal agents and a decrease in fungal infections were independent predictors for survival in the months following immunosuppression among patients with persistent neutropenia.

Rajeka Lazarus and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 736–742, https://doi.org/10.1093/cid/cir003

Combined schedules of pneumococcal conjugate and polysaccharide vaccines do not provide enhanced immunogenicity for the seven serotypes tested in comparison to a single dose of pneumococcal conjugate vaccine in adults.

Esther Calbo and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 743–749, https://doi.org/10.1093/cid/ciq238

Klebsiella pneumoniae has been frequently associated with nosocomial outbreaks. A unique foodborne nosocomial outbreak due to a SHV-1 and CTX-M-15-producing K. pneumoniae is described.

REVIEW ARTICLE

Drosos E. Karageorgopoulos and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 750–770, https://doi.org/10.1093/cid/ciq206

This meta-analysis shows that serum or plasma (1←3)-β-D-glucan has pooled sensitivity of 77% and specificity of 85% for the diagnosis of proven or probable invasive fungal infections. However, there was considerable heterogeneity in the characteristics of the 16 analyzed studies.

BRIEF REPORTS

Oriol Mitjà and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 771–774, https://doi.org/10.1093/cid/ciq246
Caroline J. Lee and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 775–778, https://doi.org/10.1093/cid/cir026

PHOTO QUIZ

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Page 779, https://doi.org/10.1093/cid/ciq208

INVITED ARTICLES

HIV/AIDS

Omobolaji T. Campbell-Yesufu and Rajesh T. Gandhi
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 780–787, https://doi.org/10.1093/cid/ciq248

FOOD SAFETY

Nicholas A. Daniels
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 788–792, https://doi.org/10.1093/cid/ciq251

HIV/AIDS

Edward M. Gardner and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 793–800, https://doi.org/10.1093/cid/ciq243

Poor engagement in HIV care is common in the United States and worsens HIV treatment outcomes. In addition, poor engagement in care is likely to drastically reduce the effectiveness of “test and treat” HIV prevention strategies.

Joep M. A. Lange
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 801–802, https://doi.org/10.1093/cid/ciq254
G. V. Matthews and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 803–811, https://doi.org/10.1093/cid/ciq200

HCV transmission networks within the Australian Trial in Acute Hepatitis C occurred predominantly in HIV positive populations and almost exclusively in men who have sex with men. Both sexual and injecting drug use risk were observed within the same clusters.

Lynn E. Taylor and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 812–818, https://doi.org/10.1093/cid/ciq201

HCV incidence from 1996-2008 among HIV-infected men in U.S. HIV therapeutic trials was 0.51 per 100 person-years. Incident HCV occurred primarily through non-parenteral means; 75% of seroconverters reported no drug injection. At-risk HIV-infected persons should have access to HCV surveillance

Dorine Neveu and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 819–825, https://doi.org/10.1093/cid/ciq203

In a nested case-control study, postnatal HIV infection was strongly associated with cumulative HIV RNA breastmilk exposure, even after allowing for maternal CD4 and plasma viral load; cases ingested approximately 15 times more HIV-1 RNA particles than controls.

ANSWER TO THE PHOTO QUIZ

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 826–827, https://doi.org/10.1093/cid/ciq212

CORRESPONDENCE

Geoffry Mercer and Heath Kelly
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 828–829, https://doi.org/10.1093/cid/cir035
Perry R. W. Kendall
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 829–830, https://doi.org/10.1093/cid/cir037
W. Paul Glezen
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 830–831, https://doi.org/10.1093/cid/cir039
Danuta M. Skowronski and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 831–832, https://doi.org/10.1093/cid/cir036
Benjamin J. Cowling and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 832–833, https://doi.org/10.1093/cid/cir041
Chih-Cheng Lai and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages 833–835, https://doi.org/10.1093/cid/ciq255

ELECTRONIC ARTICLE

Suk See De Ravin and others
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Pages e136–e143, https://doi.org/10.1093/cid/ciq250

We report the first cases of invasive mycosis by G. argillacea in chronic granulomatous disease, CGD (an inherited disorder of the NADPH oxidase), patients. G. argillacea is a previously underappreciated and frequently misidentified pathogen in CGD that should be excluded when P. variotii is identified morphologically.

COVER

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Page NP, https://doi.org/10.1093/cid/cir156

STANDING MATERIAL

Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Page NP, https://doi.org/10.1093/cid/cir155
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Page NP, https://doi.org/10.1093/cid/cir157
Clinical Infectious Diseases, Volume 52, Issue 6, 15 March 2011, Page NP, https://doi.org/10.1093/cid/cir158
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close